CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,014 | +4.4% | 600 | +20.0% | 0.00% | – |
| Q2 2023 | $6,720 | +102.7% | 500 | +150.0% | 0.00% | – |
| Q1 2023 | $3,316 | +122.8% | 200 | +150.0% | 0.00% | – |
| Q4 2022 | $1,488 | +48.8% | 80 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -100.0% | 80 | -98.5% | 0.00% | – |
| Q1 2021 | $23,972,000 | +266255.6% | 5,200 | +108.0% | 0.00% | – |
| Q4 2019 | $9,000 | -60.9% | 2,500 | -44.4% | 0.00% | -100.0% |
| Q3 2019 | $23,000 | +155.6% | 4,500 | +80.0% | 0.00% | – |
| Q2 2019 | $9,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 2,500 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |